Infinity Total Assets vs Total Liabilities Analysis

INFI -  USA Stock  

USD 1.19  0.03  2.46%

Infinity Pharmaceuti financial indicator trend analysis is infinitely more than just investigating Infinity Pharmaceuti recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Infinity Pharmaceuti is a good investment. Please check the relationship between Infinity Pharmaceuti Total Assets and its Total Liabilities accounts. Please see Risk vs Return Analysis.

Total Assets vs Total Liabilities

Accounts Relationship

Total Assets vs Total Liabilities

Significance: Fragmental Relationship

Total Assets diversification synergy
Overlapping area represents amount of trend that can be explained by analyzing historical patterns of Infinity Pharmaceuti Total Assets account and Total Liabilities

Correlation Coefficient

0.5
Relationship DirectionPositive 
Relationship StrengthWeak

Total Assets

Total assets refers to the total amount of Infinity Pharmaceuti assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Infinity Pharmaceuti books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; [Intangibles]; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.

Total Liabilities

Deferred Income Tax is recorded on Infinity Pharmaceuti balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Infinity Pharmaceuti books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most indicators from Infinity Pharmaceuti fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Infinity Pharmaceuti current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.Infinity Pharmaceuti Net Cash Flow Investment Acquisitions and Disposals is most likely to increase significantly in the upcoming years. The last year's value of Net Cash Flow Investment Acquisitions and Disposals was reported at 16.88 Million
 2019 2020 2021 2022 (projected)
Interest Expense2.56 M2.44 M2.2 M2.19 M
Gross Profit3.05 M1.72 M1.55 M1.59 M

Infinity Pharmaceuti fundamental ratios Correlations

-0.10.170.160.180.35-0.670.26-0.680.060.35-0.26-0.26-0.07-0.29-0.05-0.380.090.210.82
-0.10.550.520.660.480.4-0.510.420.710.210.290.280.720.780.80.720.560.60.08
0.170.551.00.630.90.51-0.780.510.940.880.590.590.620.50.740.360.840.560.47
0.160.521.00.570.890.5-0.770.50.940.90.620.620.580.460.70.330.860.490.48
0.180.660.630.570.70.36-0.610.360.560.330.00.00.750.740.890.630.30.990.13
0.350.480.90.890.70.24-0.540.240.760.740.20.190.480.560.750.440.590.640.55
-0.670.40.510.50.360.24-0.881.00.540.320.670.660.550.490.540.450.470.31-0.43
0.26-0.51-0.78-0.77-0.61-0.54-0.88-0.88-0.76-0.64-0.7-0.7-0.67-0.49-0.69-0.38-0.69-0.570.03
-0.680.420.510.50.360.241.0-0.880.540.310.660.660.540.510.540.470.470.32-0.44
0.060.710.940.940.560.760.54-0.760.540.780.70.70.730.550.760.430.90.470.37
0.350.210.880.90.330.740.32-0.640.310.780.670.660.340.040.37-0.110.830.270.66
-0.260.290.590.620.00.20.67-0.70.660.70.671.00.420.030.21-0.050.8-0.050.08
-0.260.280.590.620.00.190.66-0.70.660.70.661.00.410.020.21-0.060.8-0.060.09
-0.070.720.620.580.750.480.55-0.670.540.730.340.420.410.680.850.570.430.71-0.1
-0.290.780.50.460.740.560.49-0.490.510.550.040.030.020.680.90.980.250.68-0.21
-0.050.80.740.70.890.750.54-0.690.540.760.370.210.210.850.90.80.470.830.03
-0.380.720.360.330.630.440.45-0.380.470.43-0.11-0.05-0.060.570.980.80.140.57-0.31
0.090.560.840.860.30.590.47-0.690.470.90.830.80.80.430.250.470.140.230.51
0.210.60.560.490.990.640.31-0.570.320.470.27-0.05-0.060.710.680.830.570.230.12
0.820.080.470.480.130.55-0.430.03-0.440.370.660.080.09-0.1-0.210.03-0.310.510.12
Click cells to compare fundamentals

Infinity Pharmaceuti Account Relationship Matchups

Infinity Pharmaceuti fundamental ratios Accounts

201720182019202020212022 (projected)
Accounts Payable459 K1.2 M1.62 M2.98 M3.43 M3.98 M
Accumulated Other Comprehensive Income(15 K)(4 K)12 K(1,000)(900)(923.68)
Total Assets59.35 M60.22 M49.01 M39.32 M35.39 M36.32 M
Current Assets58.39 M59.82 M44.58 M36.02 M32.42 M33.27 M
Assets Non Current967 K397 K4.43 M3.3 M2.97 M3.05 M
Cash and Equivalents34.61 M48.62 M22.26 M28.59 M25.73 M26.41 M
Cash and Equivalents USD34.61 M48.62 M22.26 M28.59 M25.73 M26.41 M
Total Debt19.59 M6 M1.93 M1.44 M1.29 M1.33 M
Total Debt USD19.59 M6 M1.93 M1.44 M1.29 M1.33 M
Shareholders Equity47.73 M52.46 M7.73 M(22.99 M)(20.69 M)(21.23 M)
Shareholders Equity USD47.73 M52.46 M7.73 M(22.99 M)(20.69 M)(21.23 M)
Investments23 M9.97 M20.5 M5.68 M5.11 M5.25 M
Investments Current23 M9.97 M20.18 M5.51 M4.96 M5.09 M
Investments Non Current1.68 M530 K315 K165 K148.5 K152.41 K
Total Liabilities11.62 M7.76 M41.29 M62.31 M56.08 M58.15 M
Current Liabilities11.6 M7.72 M9.7 M11.05 M9.94 M10.2 M
Liabilities Non Current28 K38 K31.59 M51.26 M46.13 M42.02 M
Trade and Non Trade Payables459 K1.2 M1.62 M2.98 M2.68 M2.75 M
Property Plant and Equipment Net219 K28 K3.9 M3.13 M2.82 M2.89 M
Accumulated Retained Earnings Deficit(667.52 M)(678.77 M)(725.83 M)(766.32 M)(689.69 M)(744.14 M)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.